DVT Awareness

OneBreath® Raises Awareness About Deep Vein Thrombosis (DVT)

OneBreath is working with the American College of Chest Physicians (ACCP) to educate the public about the risk factors associated with deep vein thrombosis (DVT) and pulmonary embolism (PE), conditions that affect an estimated 350,000 to 600,000 Americans each year, contributing to at least 100,000 deaths annually.

What is DVT?
Deep vein thrombosis, or DVT, is a blood clot in a deep vein, most commonly in the lower leg or thigh. The clot can block blood flow and cause pain, swelling, and skin discoloration.

What is a PE?
In the most serious cases, deep vein thrombosis can lead to a pulmonary embolism, or PE, when part of the blood clot breaks loose and travels through the bloodstream to the lungs, where it can block a lung artery, causing damage to the lungs or other organs from lack of oxygen.

What causes DVT, and who is at risk?
DVT can be caused by many different things, specifically, anything that causes your blood not to circulate normally or clot properly. Many factors can increase your risk for developing DVT, including:

  • Sitting for long periods of time, such as during long-distance travel or prolonged bed rest
  • Inheriting a blood clotting disorder
  • Injury or surgery
  • Pregnancy
  • Estrogen use, including the use of oral contraceptives (birth control)
  • Cancer
  • Advanced age
  • Obesity
  • A history of DVT or PE

What are the symptoms of DVT?
In many instances, DVT/PE occurs without noticeable symptoms. However, when symptoms do occur, they can include:

  • Swelling in the affected leg
  • Pain in the leg, that often feels like cramping in the calf
  • Warmth in the affected area
  • Changes in skin color, including turning pale, red, or blue

How is DVT/PE treated?
Through the newly published Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, the ACCP provides the most up-to-date recommendations related to the prevention, diagnosis, and treatment of DVT and PE, all based on clinical evidence. Clinicians around the world use these guidelines to determine a patient’s risk for developing DVT or PE, how to prevent the occurrence of these conditions, and how to treat the conditions to minimize complications and reoccurrence.

What do the new ACCP DVT/PE guidelines mean for patients?
The Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, are written for and intended to be used by clinicians. However, patient education guides are available that summarize the importance of the guidelines.

Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy and Pregnancy
This document highlights some frequently asked questions regarding specific information on pregnant women at risk of or diagnosed with blood clots, along with specific information and associated therapies for their condition.

A Patient's Guide to Antithrombotic and Thrombolytic Therapy: This document highlights some frequently asked questions regarding general information on how blood clots develop, how they can be prevented, and how they are treated.

A Patient's Guide to Antithrombotic Therapy in Atrial Fibrillation: This document highlights some frequently asked questions regarding an overview of atrial fibrillation and specific information on how blood clots develop, how stroke may occur, and the therapies that may help you reduce your risk.

A Patient's Guide to Antithrombotic Therapy in Stroke: This document highlights some frequently asked questions regarding specific information on how ischemic strokes may occur and therapies that may help reduce this risk.

A Patient's Guide to Perioperative Antithrombotic Therapy: How Your Blood-Thinning Medications Are Managed Before and After Surgery: This document highlights some frequently asked questions regarding patients about to undergo surgery, as well as specific information regarding management of their blood clotting medications before and after surgery.

A Patient's Guide to Antithrombotic and Thrombolytic Therapy in Neonates and Children: This document highlights some frequently asked questions concerning blood clots and associated therapies specifically for neonates and children.

The Primary and Secondary Prevention of Cardiovascular Disease: This document highlights some frequently asked questions regarding specific information on how cardiovascular disease may occur and primary and secondary prevention strategies that may help you reduce your risk.